Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: TokyoMex who wrote (3467)	12/12/1997 12:17:00 AM
From: Anaxagoras	Respond to of 23519

Thanks for the good notes, Tokyo. Just to add thereto- when I was still fresh at the beginning of the call during the prepared (more or less) remarks of Williams, I took down some of what I thought were his most important remarks. Here they are, verbatim. Anaxagoras ~~~~~~~~~~~~~~ <<I want to state here today that there is no plan at this point to delay that consumer advertising campaign in February. We believe that we are adequately covered both from the regulatory approval process in our existing facility and the new facility both from the MCA and the US agency FDA, that we are comfortable with launching that direct-to-the-consumer kind of add campaign and other kinds of activities in February of this coming year. And clearly we are doing other things too. Many of you know that we have added 25 additional sales representatives at this time. Those people are trained and are entering into the field and will be there in earnest January 1. So we'll have that as an increased demand generation. We're also rolling out a program so that we increase the promotional effort directly to the physicians themselves. But all of you should know that this is a patient driven market. The patients must get off the couch and come into the physician's office in order to increase the demand for this product. And so how do you get more patients into the market? You do it through public relations or demand generation, direct-to-the-consumer ad campaigns. The only thing that we have used was the public relations activity around the NEJM which carried us through January, February, and March of this previous year and we're now ready to launch that direct-to-the-consumer ad campaign. So my view is that we are pretty close to being on schedule as we had anticipated very early in the year, both from the new manufacturing plant and also as far as our launch of our consumer programs on the marketing side.>> Also, in contrast to others, I thought that there were quite a few good questions posed on the call- the analysts did a pretty good job, IMO. Management gets a generous 7 out of 10 score for the call, IMO. I'm holding till February. FWIW, Anaxagoras